SCHEMBL19976801

SCHEMBL19976801

CC(C)(C)N/C(=N/C(=O)c1ccc(F)c(F)c1)Nc1n[nH]c2c(F)cccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.37
ANO1 Q5XXA6 2/20 0.36
HDAC6 Q9UBN7 3/20 0.35
CHRNA1 P02708 1/20 0.34
CHRNG P07510 1/20 0.34
CHRNB1 P11230 1/20 0.34
CHRNB2 P17787 1/20 0.34
SLC6A2 P23975 1/20 0.34
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
CHRNA4 P43681 1/20 0.34
SLC6A3 Q01959 1/20 0.34
CHRND Q07001 1/20 0.34
CDK2 P24941 3/20 0.34
CDK1 P06493 2/20 0.34
FLT4 P35916 2/20 0.34
MAPK8 P45983 2/20 0.34
CLK2 P49760 2/20 0.34
GSK3B P49841 2/20 0.34
CDK5 Q00535 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19976804 0.91 TRPA1 (0.37) TRPA1ANO1HDAC6CHRNA1CHRNG
SCHEMBL19976730 0.87 HDAC6 (0.41) HDAC6CDK2CDK1FLT4MAPK8
SCHEMBL19976785 0.86 MAPK1 (0.38) TRPA1HDAC6CDK2CDK1FLT4
SCHEMBL19976929 0.85 RIPK1 (0.37) HDAC6CHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL19976726 0.84 ABL1 (0.41) HDAC6CHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL19976857 0.84 MAPK1 (0.35) TRPA1HDAC6CDK2CDK1FLT4
SCHEMBL19976765 0.82 NTRK1 (0.41) ANO1HDAC6CDK2CDK1FLT4
SCHEMBL16752857 0.82 CHRNA1 (0.34) ANO1CHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL16752855 0.82 CHRNA1 (0.34) ANO1CHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL19976768 0.81 MAPK1 (0.38) TRPA1HDAC6CDK2CDK1FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9920012-B2 Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-20 US disclosed